Skip to content

Reducing prehospital delay in Acute Myocardial Infarction

A randomised control trial to evaluate the effect of a individualised teaching intervention on the response of patientâ¿¿s with coronary heart disease to symptoms of myocardial infarction.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000165684
Acronym
PROMOTION
Enrollment
5400
Registered
2005-08-16
Start date
2000-05-16
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

54oo patients with documented ischaemic heart disease were randomised to the experimental intervention or to a care-as-usual group at six participating sites. The intervention group received face-to-face counselling about the symptoms of AMI and the importance of seeking treatment early, as well as emergency medical system (EMS) and aspirin use. They also received telephonic reinforcement of the intervention at one month follow-up. Data are collected at baseline, immediately following the interv

54oo patients with documented ischaemic heart disease were randomised to the experimental intervention or to a care-as-usual group at six participating sites. The intervention group received face-to-face counselling about the symptoms of AMI and the importance of seeking treatment early, as well as emergency medical system (EMS) and aspirin use. They also received telephonic reinforcement of the intervention at one month follow-up. Data are collected at baseline, immediately following the intervention, 3, 12 and 24 months. Instruments to be used include teh Response Questionnnaire, Cardiac Control Index, Brief Symptom Inventory Anxiety Subscale and teh Resource Utilisation Interview. Pre-hospital delay, EMS use, aspirin use and resource utilisation are evaluated by means of medical record review and patient interview

Sponsors

Professor Kathleen Dracup, The University of California, San Francisco
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Factorial
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No

Inclusion criteria

1. Have a diagnosis of ischaemic heart disease and 2. live independently.

Exclusion criteria

1. a complicating serious co morbidity such as a psychiatric illness 2. untreated malignancy or neurological disorder which impairs cognition, 3. unable to understand spoken English and unable to respond to English language questions in the data collection instrument, 4. a major and uncorrected hearing loss.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026